Construction of JinMed's New Facility Begins in Chuzhou, China
JIN MEDICAL INTERNATIONAL (NASDAQ: ZJYL), a leader in Assistive Technologies (AT) and manufacturer of wheelchairs and living aids, has announced the start of construction for its new manufacturing facility in Chuzhou City, Anhui Province, China. The facility, operated by JinMed (Anhui) Co., , will be an internationally standardized, innovative, and high-end wheelchair manufacturing plant.
The new facility is expected to strengthen JinMed's position in the AT industry with higher-level production lines and more innovative products. Targeted to operate in 2025, it will expand capacity for manual wheelchairs and introduce production lines for electric wheelchairs, electric scooters, micro hyperbaric chambers, and scientific cosmetic products.
CEO Wang Erqi stated that this development marks a major milestone for JinMed, aligning with their goal of 'global technology for the benefit of mankind' and demonstrating the company's commitment to industry leadership.
JIN MEDICAL INTERNATIONAL (NASDAQ: ZJYL), leader nelle Tecnologie Assistive (AT) e produttore di carrozzine e ausili per la vita, ha annunciato l'inizio della costruzione del suo nuovo stabilimento di produzione nella città di Chuzhou, nella provincia di Anhui, Cina. Lo stabilimento, gestito da JinMed (Anhui) Co., , sarà un impianto di produzione di carrozzine innovativo, di alta gamma e conforme agli standard internazionali.
Il nuovo stabilimento dovrebbe rafforzare la posizione di JinMed nel settore delle AT con linee di produzione di livello superiore e prodotti più innovativi. Prevedendo di entrare in funzione nel 2025, espanderà la capacità per le carrozzine manuali e introdurrà linee di produzione per carrozzine elettriche, scooter elettrici, camere iperbariche micro e prodotti cosmetici scientifici.
Il CEO Wang Erqi ha dichiarato che questo sviluppo segna una tappa fondamentale per JinMed, allineandosi con il loro obiettivo di 'tecnologia globale a beneficio dell'umanità' e dimostrando l'impegno dell'azienda nella leadership del settore.
JIN MEDICAL INTERNATIONAL (NASDAQ: ZJYL), líder en Tecnologías Asistivas (AT) y fabricante de sillas de ruedas y ayudas para la vida, ha anunciado el inicio de la construcción de su nueva instalación de fabricación en la ciudad de Chuzhou, en la provincia de Anhui, China. La instalación, operada por JinMed (Anhui) Co., , será una planta de fabricación de sillas de ruedas innovadora, de alto nivel y estandarizada a nivel internacional.
Se espera que la nueva instalación fortalezca la posición de JinMed en la industria de AT con líneas de producción de nivel superior y productos más innovadores. Prevista para operar en 2025, ampliará la capacidad para sillas de ruedas manuales e introducirá líneas de producción para sillas de ruedas eléctricas, scooters eléctricos, cámaras hiperbáricas micro y productos cosméticos científicos.
El CEO Wang Erqi declaró que este desarrollo marca un hito importante para JinMed, alineándose con su objetivo de 'tecnología global para el beneficio de la humanidad' y demostrando el compromiso de la empresa con el liderazgo en la industria.
JIN MEDICAL INTERNATIONAL (NASDAQ: ZJYL)는 보조기술(AT)의 선두주자이자 휠체어 및 생활 보조 기기의 제조업체로, 중국 안후이성 추저우시에 새로운 제조 시설 건설을 시작한다고 발표했습니다. 이 시설은 JinMed (Anhui) Co., 에 의해 운영되며, 국제 표준을 준수하는 혁신적이고 고급 휠체어 제조 공장이 될 것입니다.
새로운 시설은 더 높은 수준의 생산 라인과 더 혁신적인 제품으로 JinMed의 AT 산업 내 입지를 강화할 것으로 예상됩니다. 2025년부터 운영할 예정이며, 수동 휠체어의 생산 능력을 확장하고 전기 휠체어, 전기 스쿠터, 미세 고압 챔버 및 과학적 화장품 생산 라인을 도입할 것입니다.
CEO 왕얼치(Wang Erqi)는 이 발전이 JinMed에게 큰 이정표를 의미하며, '인류를 위한 글로벌 기술'이라는 목표와 일치하고 회사의 산업 리더십에 대한 의지를 보여준다고 밝혔습니다.
JIN MEDICAL INTERNATIONAL (NASDAQ: ZJYL), un leader dans les Technologies d'Assistance (AT) et fabricant de fauteuils roulants et d'aides à la vie, a annoncé le début des travaux de construction de sa nouvelle installation de fabrication dans la ville de Chuzhou, dans la province d'Anhui, en Chine. L'installation, exploitée par JinMed (Anhui) Co., , sera une usine de fabrication de fauteuils roulants conforme aux normes internationales, innovante et haut de gamme.
La nouvelle installation devrait renforcer la position de JinMed dans l'industrie des AT avec des lignes de production de niveau supérieur et des produits plus innovants. Prévue pour être opérationnelle en 2025, elle augmentera la capacité pour les fauteuils roulants manuels et introduira des lignes de production pour les fauteuils roulants électriques, les scooters électriques, les chambres hyperbares et les produits cosmétiques scientifiques.
Le PDG Wang Erqi a déclaré que ce développement constitue une étape majeure pour JinMed, s'alignant sur leur objectif de 'technologie mondiale au bénéfice de l'humanité' et démontrant l'engagement de l'entreprise envers le leadership dans l'industrie.
JIN MEDICAL INTERNATIONAL (NASDAQ: ZJYL), ein führendes Unternehmen für Assistive Technologien (AT) und Hersteller von Rollstühlen und Lebenshilfen, hat den Baustart für seine neue Produktionsstätte in der Stadt Chuzhou, Provinz Anhui, China, angekündigt. Die Einrichtung, die von JinMed (Anhui) Co., betrieben wird, wird ein innovatives und hochwertiges Rollstuhlwerk sein, das internationalen Standards entspricht.
Die neue Einrichtung wird voraussichtlich JinMeds Position in der AT-Branche mit hochmodernen Produktionslinien und innovativeren Produkten stärken. Sie soll im 2025 betrieben werden und die Kapazität für manuelle Rollstühle erweitern sowie Produktionslinien für elektrische Rollstühle, elektrische Roller, Mikrohyperbare Kammern und wissenschaftliche Kosmetikprodukte einführen.
CEO Wang Erqi erklärte, dass diese Entwicklung einen wichtigen Meilenstein für JinMed darstellt, der im Einklang mit ihrem Ziel von 'globaler Technologie zum Wohle der Menschheit' steht und das Engagement des Unternehmens für die Branchenführerschaft demonstriert.
- Construction of new manufacturing facility in Chuzhou City, China
- Expansion of production capacity for manual wheelchairs
- Introduction of new product lines including electric wheelchairs and scooters
- Diversification into healthcare products like micro hyperbaric chambers and scientific cosmetic products
- Expected strengthening of company's leadership in the AT industry
- None.
Insights
The construction of JinMed's new facility in Chuzhou marks a significant expansion of their production capabilities. This move indicates strong growth prospects and potential market share gains in the Assistive Technologies sector. The facility's focus on internationally standardized, innovative and high-end wheelchair manufacturing suggests a push towards premium products and potentially higher profit margins.
The diversification into electric wheelchairs, scooters and healthcare products like micro hyperbaric chambers demonstrates JinMed's strategy to broaden its product portfolio. This could lead to increased revenue streams and reduced reliance on a single product line. However, entering new product categories also carries risks, including potential R&D costs and market acceptance challenges.
The targeted operation date of 2025 gives the company a reasonable timeline for construction and setup. This expansion could position JinMed to better meet growing demand in the assistive technology market, especially given the aging population trends in many countries. Investors should monitor progress on the facility's completion and its impact on production capacity and financial performance once operational.
JinMed's expansion into Chuzhou reflects a strategic move to capitalize on the growing global Assistive Technologies market. The AT industry is projected to see significant growth due to aging populations and increased focus on accessibility, presenting a favorable market environment for JinMed's expansion.
The company's decision to diversify its product line beyond manual wheelchairs to include electric wheelchairs, scooters and healthcare products aligns with market trends towards more technologically advanced and specialized assistive devices. This diversification could help JinMed capture a larger market share and tap into higher-value product segments.
However, the success of this expansion will depend on factors such as:
- Market acceptance of new product lines
- Competitive landscape in electric mobility devices
- Regulatory approvals for new healthcare products
- Economic conditions in target markets
Investors should closely monitor JinMed's ability to execute this expansion effectively and its impact on the company's market position and financial performance in the coming years.
Chuzhou City, China, Oct. 10, 2024 (GLOBE NEWSWIRE) -- JIN MEDICAL INTERNATIONAL LTD. (the "Company" or “JinMed”) (NASDAQ: ZJYL), an industrial leader in Assistive Technologies (“AT”), and a manufacturer and developer of wheelchairs and living aids products, today announced the initiation of construction of JinMed’s new manufacturing facility at Chuzhou City, Anhui Province, China. JinMed (Anhui) Co., Ltd., a newly established subsidiary of JinMed, will be designated to operate the Chuzhou JinMed plant (the “New Facility”) which is established as an internationally standardized, innovative, and high-end wheelchair and electric wheelchair manufacturing factory. With higher-level production lines in place, more innovative high-quality products are expected to strengthen JinMed’s leadership in the AT industry.
JinMed’s Chairman and Chief Executive Officer, Mr. Wang Erqi, said that the commencement of the New Facility is another major milestone for JinMed. JinMed will utilize the establishment of the New Facility as an opportunity to continue to uphold the goal of " global technology for the benefit of mankind", further strengthen its leadership in the AT industry, and demonstrate the responsibility and commitment of JinMed.
The new Chuzhou facility is targeted to operate in 2025. In addition to the expansion of capacity of JinMed’s current manual wheelchair lines, JinMed will also produce electric wheelchairs and electric scooter specialty lines. Healthcare products such as micro hyperbaric chambers and scientific cosmetic products will also be in production at the New Facility.
About Jin Medical International Ltd.
Founded in 2006 and headquartered at Changzhou, Jiangsu Province of China, JinMed, designs, develops, manufactures and markets wheelchairs and living aids products for people with disabilities, the elderlies, and for rehabilitation application. Currently, JinMed operates two manufacturing plants with approximately 230,000 square feet in the aggregate in Changzhou City and Taizhou City, Jiangsu Province, China. JinMed is establishing a new facility with 430,000 square feet at Chuzhou, Anhui Province, China. JinMed has more than 40 distributors in China and more than 20 international distributors. The majority of JinMed’s wheelchair products, with more than 30 models, are sold to distributors in Japan and China, including Nissin Medical Industries Co., Ltd, one of the largest medical device distributors in Japan. JinMed continuously deliver innovative wheelchair products that are both lightweight and ergonomic. For more information, please visit: http://www.zhjmedical.com.
Forward-Looking Statement
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performances, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to, the following: the Company's ability to achieve its goals and strategies, the Company's future business development and plans for future business development, including its financial conditions and results of operations, product and service demand and acceptance, reputation and brand, the impact of competition and pricing, changes in technology, government regulations, fluctuations in general economic and business conditions, and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission (“SEC”). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, as well as its current reports on Form 6-K and other filings, all of which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.
For more information, please contact:
FAQ
When is JinMed's new manufacturing facility in Chuzhou, China expected to begin operations?
What new product lines will be produced at JinMed's (ZJYL) Chuzhou facility?
How does JinMed (ZJYL) expect the new Chuzhou facility to impact its market position?
What is the purpose of JinMed's (ZJYL) new manufacturing facility in Chuzhou?
